Home > PE Ratio > BLISS GVS PHARMA

BLISS GVS PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of BLISS GVS PHARMA is 13.11.

Share Price ₹112.7Mar 28,2024
Market Cap ₹1,179.4 Cr
Earnings-TTM₹90.0 CrTTM-Consolidated Results
Price/Earnings13.11xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of BLISS GVS PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BLISS GVS PHARMA is calculated as :

Current Market Cap [ ₹1,179.4 Cr] as on Mar 28,2024

(/) Earnings [ ₹90.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 13.11x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BLISS GVS PHARMA , the investors are currently willing to pay 13.11 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BLISS GVS PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BLISS GVS PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of BLISS GVS PHARMA


PE Ratio Performance Analysis for BLISS GVS PHARMA

- BLISS GVS PHARMA 's latest p/e ratio is 13.11x.

- BLISS GVS PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 20.81x.

- BLISS GVS PHARMA 's operated at median p/e ratio of 14.86x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BLISS GVS PHARMA 's p/e ratio peaked in Mar2022 at 53.04x.

- BLISS GVS PHARMA 's p/e ratio hit its five-year low in Mar2023 of 10.47x.


How does BLISS GVS PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BLISS GVS PHARMA 89.9613.111,179.4
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6343.21388,812.0
CIPLA LTD3,744.0332.23120,673.0
DR REDDYS LABORATORIES LTD5,209.4019.71102,679.0
ZYDUS LIFESCIENCES LTD2,954.2034.24101,152.0
DIVIS LABORATORIES LTD1,382.9765.9791,234.9
MANKIND PHARMA LTD1,743.3052.7992,029.2
TORRENT PHARMACEUTICALS LTD1,494.0058.9388,034.7
LUPIN LTD1,809.7440.7473,722.0
AUROBINDO PHARMA LTD2,777.8922.9863,835.1
ABBOTT INDIA LTD1,145.5849.9857,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BLISS GVS PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 13.11x
Max industry PE 65.97x
Median industry PE 40.74x
Average industry PE 39.44x



You may also like the below Video Courses